Dr Reddys Laboratories Share Price Today - Live Blog for September 24, 2025

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,298.50 per share. Investors are taking notice of this upward momentum.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.07%, signalling a challenging period. Currently trading at ₹1,297.55, this stock has caught the eye of bargain hunters, who may be considering their entry points.

There was no alteration in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,297.80. This lack of change could lead investors to revisit their investment strategies and consider the stock's valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.18% drop, and it's now trading at ₹1,297.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

After a -0.28% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,299.30. The stock has a PE ratio of 19.1200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.09%, and it's currently trading at ₹1,303.00. The stock maintains a PE of 19.1200, while the industry PE is 35.7722, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹1,304.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.03%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,303.35 per share.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,303.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.1200, while the industry PE is 35.7722.

Dr Reddys Laboratories Ltd's stock has surged by 0.05%, and it is currently trading at ₹1,305.60. Additionally, the stock maintains a PE ratio of 19.1200, while the industry PE is 35.7722.

Dr Reddys Laboratories Ltd share price surged by 0.12%. With its current market price standing at ₹1,305.00 per share, this stock is garnering increased attention from the investment community.

After a significant 0.21% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,303.50 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.20% uptick in its share price. As a result, it's now actively trading at ₹1,300.75 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.20% uptick in its share price. As a result, it's now actively trading at ₹1,300.75 per share, making it an attractive option for investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.20% gain, with the share price now at ₹1,300.75. Notably, the stock's PE ratio stands at 19.1200, and its Return on Equity (ROE) is 16.8559%.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.37% in its share price, and it currently trades at ₹1,298.20 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,303.00, but investors are assessing whether this is a temporary dip or a long-term trend.

After a notable 0.11% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,306.35. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.01% boost, with the current market value at ₹1,304.85 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's share price rallied by 0.11%, reaching the current market price of ₹1,304.70. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd observed a remarkable 0.02% surge in its share price and is presently trading at ₹1,302.50. The increased investor interest is driving this surge.

With a remarkable 0.02% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,302.25. Notably, this stock has a Price-to-Earnings (PE) ratio of 19.1200, while the industry's PE ratio is 35.7722.

After a -0.02% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,302.00. The stock has a PE ratio of 19.1200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.23% decline and is currently trading at ₹1,303.30 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.21% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,306.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a notable 0.12% surge in its share price and is presently trading at ₹1,303.20, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.13% drop, and it's now trading at ₹1,301.60 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.16% gain, with the share price now at ₹1,302.70. Notably, the stock's PE ratio stands at 19.1200, and its Return on Equity (ROE) is 16.8559%.